Chris Jewell
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Profil
Chris Jewell is currently a Professor at the University of Maryland and the Chief Scientific Officer at Cartesian Therapeutics, Inc. He previously held the position of Chief Scientific Officer at Cartesian Therapeutics, Inc. in 2023.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Chris Jewell
| Sociétés | Poste | Début |
|---|---|---|
| University of Maryland | Corporate Officer/Principal | - |
Anciens postes connus de Chris Jewell
| Sociétés | Poste | Fin |
|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Directeur Technique/Scientifique/R&D | 13/11/2023 |
Formation de Chris Jewell
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
